Cardiac arrhythmia modelling using iPS cells

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Innovation in stem cell biology has greatly impacted on medical researches. The generation of induced pluripotent stem cell (iPSC) established the novel concept not only in regenerative medicine but also disease modelling. There are several reports that disease-specific iPSC-derived cells have recapitulated cellular phenotypes of wide varieties of diseases. The disease-specific iPSCs are utilised to understand unknown pathogenesis by in vitro examination of disease-specific iPSC-derived cells. It is also shown that disease-specific iPSC-derived cells can be applied to high throughput screening for new drugs. Early reports about disease modelling using iPSCs focused on various types of cardiac arrhythmia because it is difficult to model human arrhythmia in animal models such as a genetically engineered mouse and it is relatively clear to show the phenotypes of cardiac arrhythmia in iPSC-derived cardiomyocyte such as abnormal electrophysiological activities. In this chapter, we focus on the conceptual and practical issues about cardiac arrhythmia modelling using disease-specific iPSCs and discuss the future directions.

Original languageEnglish
Title of host publicationHuman iPS Cells in Disease Modelling
PublisherSpringer Japan
Pages45-51
Number of pages7
ISBN (Electronic)9784431559665
ISBN (Print)9784431559641
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Cardiac Arrhythmias
Induced Pluripotent Stem Cells
Stem cells
Cytology
Phenotype
Preclinical Drug Evaluations
Regenerative Medicine
Cardiac Myocytes
Cell Biology
Biomedical Research
Screening
Animals
Stem Cells
Animal Models
Innovation
Throughput
Pharmaceutical Preparations

Keywords

  • Arrhythmia
  • Disease model
  • Heart
  • IPS cell

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Yuasa, S. (2016). Cardiac arrhythmia modelling using iPS cells. In Human iPS Cells in Disease Modelling (pp. 45-51). Springer Japan. https://doi.org/10.1007/978-4-431-55966-5_4

Cardiac arrhythmia modelling using iPS cells. / Yuasa, Shinsuke.

Human iPS Cells in Disease Modelling. Springer Japan, 2016. p. 45-51.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yuasa, S 2016, Cardiac arrhythmia modelling using iPS cells. in Human iPS Cells in Disease Modelling. Springer Japan, pp. 45-51. https://doi.org/10.1007/978-4-431-55966-5_4
Yuasa S. Cardiac arrhythmia modelling using iPS cells. In Human iPS Cells in Disease Modelling. Springer Japan. 2016. p. 45-51 https://doi.org/10.1007/978-4-431-55966-5_4
Yuasa, Shinsuke. / Cardiac arrhythmia modelling using iPS cells. Human iPS Cells in Disease Modelling. Springer Japan, 2016. pp. 45-51
@inbook{6b30b2ccc5bf4781bce8d7e3f09f61a8,
title = "Cardiac arrhythmia modelling using iPS cells",
abstract = "Innovation in stem cell biology has greatly impacted on medical researches. The generation of induced pluripotent stem cell (iPSC) established the novel concept not only in regenerative medicine but also disease modelling. There are several reports that disease-specific iPSC-derived cells have recapitulated cellular phenotypes of wide varieties of diseases. The disease-specific iPSCs are utilised to understand unknown pathogenesis by in vitro examination of disease-specific iPSC-derived cells. It is also shown that disease-specific iPSC-derived cells can be applied to high throughput screening for new drugs. Early reports about disease modelling using iPSCs focused on various types of cardiac arrhythmia because it is difficult to model human arrhythmia in animal models such as a genetically engineered mouse and it is relatively clear to show the phenotypes of cardiac arrhythmia in iPSC-derived cardiomyocyte such as abnormal electrophysiological activities. In this chapter, we focus on the conceptual and practical issues about cardiac arrhythmia modelling using disease-specific iPSCs and discuss the future directions.",
keywords = "Arrhythmia, Disease model, Heart, IPS cell",
author = "Shinsuke Yuasa",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-4-431-55966-5_4",
language = "English",
isbn = "9784431559641",
pages = "45--51",
booktitle = "Human iPS Cells in Disease Modelling",
publisher = "Springer Japan",

}

TY - CHAP

T1 - Cardiac arrhythmia modelling using iPS cells

AU - Yuasa, Shinsuke

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Innovation in stem cell biology has greatly impacted on medical researches. The generation of induced pluripotent stem cell (iPSC) established the novel concept not only in regenerative medicine but also disease modelling. There are several reports that disease-specific iPSC-derived cells have recapitulated cellular phenotypes of wide varieties of diseases. The disease-specific iPSCs are utilised to understand unknown pathogenesis by in vitro examination of disease-specific iPSC-derived cells. It is also shown that disease-specific iPSC-derived cells can be applied to high throughput screening for new drugs. Early reports about disease modelling using iPSCs focused on various types of cardiac arrhythmia because it is difficult to model human arrhythmia in animal models such as a genetically engineered mouse and it is relatively clear to show the phenotypes of cardiac arrhythmia in iPSC-derived cardiomyocyte such as abnormal electrophysiological activities. In this chapter, we focus on the conceptual and practical issues about cardiac arrhythmia modelling using disease-specific iPSCs and discuss the future directions.

AB - Innovation in stem cell biology has greatly impacted on medical researches. The generation of induced pluripotent stem cell (iPSC) established the novel concept not only in regenerative medicine but also disease modelling. There are several reports that disease-specific iPSC-derived cells have recapitulated cellular phenotypes of wide varieties of diseases. The disease-specific iPSCs are utilised to understand unknown pathogenesis by in vitro examination of disease-specific iPSC-derived cells. It is also shown that disease-specific iPSC-derived cells can be applied to high throughput screening for new drugs. Early reports about disease modelling using iPSCs focused on various types of cardiac arrhythmia because it is difficult to model human arrhythmia in animal models such as a genetically engineered mouse and it is relatively clear to show the phenotypes of cardiac arrhythmia in iPSC-derived cardiomyocyte such as abnormal electrophysiological activities. In this chapter, we focus on the conceptual and practical issues about cardiac arrhythmia modelling using disease-specific iPSCs and discuss the future directions.

KW - Arrhythmia

KW - Disease model

KW - Heart

KW - IPS cell

UR - http://www.scopus.com/inward/record.url?scp=84978289611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978289611&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-55966-5_4

DO - 10.1007/978-4-431-55966-5_4

M3 - Chapter

AN - SCOPUS:84978289611

SN - 9784431559641

SP - 45

EP - 51

BT - Human iPS Cells in Disease Modelling

PB - Springer Japan

ER -